tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Michael Petusky, 359 are a BUY (89.75%), 39 are a HOLD (9.75%), 2 are a SELL (0.5%).
Analyst Michael Petusky, currently employed at BARRINGTON, carries an average stock price target met ratio of 59.73% that have a potential upside of 26.68% achieved within 250 days.
Michael Petusky’s has documented 760 price targets and ratings displayed on 23 stocks. The coverage is on Healthcare, Consumer Defensive, Technology, Utilities sectors.
Most recent stock forecast was given on OPK, Opko Health at 16-Oct-2026.
Analyst best performing recommendations are on BVS (BIOVENTUS).
The best stock recommendation documented was for ANIK (ANIKA THERAPEUTICS) at 11/9/2022. The price target of $31 was fulfilled within 1 day with a profit of $1.4 (4.73%) receiving and performance score of 47.3.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 31-Jul-2025
$21
$-0.42 (-1.96%)
$16
2 months 26 days ago
(30-Jul-2026)
2/2 (100%)
$2.93 (16.21%)
134
Buy Since 03-Nov-2023
$17
$1.9 (12.58%)
$16
7 months 29 days ago
(27-Feb-2026)
14/22 (63.64%)
$2.64 (18.38%)
129
Hold Since 14-Oct-2022
$24
$8.9 (58.94%)
$23
2 years 4 months 27 days ago
(29-May-2024)
5/5 (100%)
$-1.64 (-6.40%)
129
Buy Since 09-Aug-2023
$32
$10.58 (49.39%)
3 years 2 months 17 days ago
(09-Aug-2023)
1/2 (50%)
$11.99 (59.92%)
73
Buy Since 15-Nov-2021
$35
$13.58 (63.40%)
$55
4 years 7 months 17 days ago
(09-Mar-2022)
0/2 (0%)
$8.78 (33.49%)
Which stock is Michael Petusky most bullish on?
Which stock is Michael Petusky most reserved on?
What Year was the first public recommendation made by Michael Petusky?
